Fresno, CA6 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Fresno, CA

Find 6 actively recruiting myalgic encephalomyelitis clinical trials in Fresno, CA. Connect with local research sites and explore new treatment options.

6
Active Trials
6
Sponsors
21,879
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Fresno

About Myalgic Encephalomyelitis Clinical Trials in Fresno

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 6 myalgic encephalomyelitis clinical trials recruiting participants in Fresno, CA. These studies are seeking a combined 21,879 participants. Research is being sponsored by Duke University, ACADIA Pharmaceuticals Inc., Suven Life Sciences Limited and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Fresno — FAQ

Are there myalgic encephalomyelitis clinical trials in Fresno?

Yes, there are 6 myalgic encephalomyelitis clinical trials currently recruiting in Fresno, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fresno?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fresno research site will contact you about next steps.

Are clinical trials in Fresno free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fresno studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 6 active trials in Fresno are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 19, 2026 from ClinicalTrials.gov